Dawn Rogers
Executive Vice President, Pfizer.
Companies
- DXC TechnologyBoard member Mar 15, 2021 to now1
- PfizerExecutive Vice President Jun 8, 2018 to Jun 16, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
DXC Technology DXC79,300 shares3$1.1M at $13.61Aug 4, 2026
Pfizer PFE14,641 shares4$432.5K at $29.54May 1, 2020
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 4, 2026Granted 21,800 shares of DXC Technology3
- Aug 5, 2025Granted 18,100 shares of DXC Technology5
- Aug 13, 2024Granted 12,300 shares of DXC Technology6
- Aug 7, 2023Granted 12,400 shares of DXC Technology7
- Jul 29, 2022Granted 6,300 shares of DXC Technology8
- Apr 29, 2020Sold 13,000 shares at $38.13 of Pfizer4
- Feb 28, 2020Shares withheld for tax 9,208 shares at $36.45 of Pfizer9
- Feb 28, 2020Shares withheld for tax 3,014 shares at $33.42 of Pfizer9
- Feb 28, 2020Exercised options 17,824 shares at $27.37 of Pfizer9
- Feb 26, 2020Shares withheld for tax 11,524 shares at $36.80 of Pfizer10
- Feb 26, 2020Shares withheld for tax 1,250 shares at $34.72 of Pfizer10
- Feb 26, 2020Exercised options 15,097 shares at $34.59 of Pfizer10
- Feb 23, 2020Shares withheld for tax 1,015 shares at $35.72 of Pfizer11
- Apr 29, 2019Shares withheld for tax 4,255 shares at $39.59 of Pfizer12
- Mar 4, 2019Sold 13,802 shares at $42.98 of Pfizer13
- Mar 4, 2019Sold 1,200 shares at $42.99 of Pfizer13
- Feb 27, 2019Shares withheld for tax 11,917 shares at $42.31 of Pfizer14
- Feb 27, 2019Shares withheld for tax 3,210 shares at $42.93 of Pfizer14
- Feb 27, 2019Granted 4,943 shares of Pfizer14
- Feb 27, 2019Exercised options 19,297 shares at $32.23 of Pfizer14
- Feb 25, 2019Shares withheld for tax 1,233 shares at $43.08 of Pfizer15
- Feb 23, 2019Shares withheld for tax 6,007 shares at $41.91 of Pfizer15
- Feb 23, 2019Shares withheld for tax 4,646 shares at $42.96 of Pfizer15
- Feb 23, 2019Exercised options 19,290 shares at $21.03 of Pfizer15
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Apr 29, 2020 | PFE | Sale | $495.7K | −18.6% | +181.8% | +36.5% |
| Mar 4, 2019 | PFE | Sale | $644.8K | −28.0% | +204.2% | +27.8% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARDXC Technology, Board member
- 2SEC EDGARPfizer, Executive Vice President
- 3
- 4
- 5SEC EDGARForm 4 filed Aug 7, 2025
- 6SEC EDGARForm 4 filed Aug 15, 2024
- 7SEC EDGARForm 4 filed Aug 9, 2023
- 8SEC EDGARForm 4 filed Aug 2, 2022
- 9SEC EDGARForm 4 filed Mar 3, 2020
- 10SEC EDGARForm 4 filed Feb 28, 2020
- 11SEC EDGARForm 4 filed Feb 25, 2020
- 12SEC EDGARForm 4 filed May 1, 2019
- 13SEC EDGARForm 4 filed Mar 5, 2019
- 14SEC EDGARForm 4 filed Mar 1, 2019
- 15SEC EDGARForm 4 filed Feb 26, 2019